I Nyoman Gde Sudana
Department of Clinical Pathology, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

MONOCYTE CELL COMPLEXITY (MO-X) AS A PREDICTOR OF DIABETIC ULCERS IN TYPE 2 DIABETES MELLITUS PATIENTS I Made Bayu Wiratama; I Nyoman Wande; I Nyoman Gde Sudana; Sianny Herawati; Ni Kadek Mulyantari
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 3 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i3.2703

Abstract

Diabetic foot ulcers (DFUs) are a common complication of type 2 diabetes mellitus associated with chronic inflammation and impaired wound healing. Monocyte cell complexity (MO-X), a cell population data parameter obtained from automated hematology analyzers, may reflect immune activation and inflammatory status. This case-control study was conducted at Ngoerah Hospital, Denpasar, from February to June 2024. Fifty-four participants were enrolled, including 27 patients with DFUs and 27 controls without DFUs. Monocyte cell complexity (MO-X) values were measured using a Sysmex XN-3000 analyzer. Data were analyzed using receiver operating characteristic (ROC) curve analysis, chi-square test, and odds ratio calculation. Monocyte cell complexity (MO-X) values were significantly higher in the DFUs group than in the control group (p < 0.001). The ROC analysis demonstrated an area under the curve (AUC) of 0.721 (95% CI: [6.22–126.06]), with an optimal cutoff value of 117.45, yielding 77.8% sensitivity and 88.9% specificity. Patients with elevated MO-X values had a 28-fold higher risk of DFUs (OR = 28.00; 95% CI: 6.22–126.06; p <0.001). Elevated MO-X values are strongly associated with the presence of DFUs, suggesting that MO-X may serve as a rapid and non-invasive biomarker for identifying diabetic patients at increased risk of ulcer development. Further multicenter studies are required to validate these findings.
Diagnostic Value of NE-WY and MO-WY for Rapid Identification Acute Leukemia Fisky Gilbert Asa Maramis; Anak Agung Wiradewi Lestari; I Nyoman Wande; I Nyoman Gde Sudana; Sianny Herawati
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.2830

Abstract

Rapid identification of acute leukemia is essential for its management. In resource-limited settings, simple, fast, and non-invasive initial screening methods are crucial for early detection. Cell population data (CPD) obtained from an automated hematology analyzer provides a new approach to identify acute leukemia quickly. Determine the ability of the width of dispersion of neutrophil fluorescence (NE-WY) and the width of dispersion of monocyte fluorescence (MO-WY), in rapidly identifying acute leukemia. The research was performed at Ngoerah Hospital Bali, focusing on patients recently diagnosed with acute leukemia. NE-WY and MO-WY values were measured using the Sysmex XN-3000 device. The study included healthy controls who had a medical check-up, and reactive controls, specifically patients with infections or inflammatory conditions. Patients who relapsed or previously received chemotherapy were excluded. A total of 228 subjects were involved in this study: 78 acute leukemia patients, 80 healthy controls, and 70 reactive controls. Distinguishing leukemia from healthy controls, the NE-WY cut-off value was 689, with sensitivity; 92.3%, specificity; 100% (p <0.001). While distinguishing from reactive controls, the cut-off value of NE-WY 857.5 was obtained, with sensitivity; 70.5%, specificity; 82.9% (p <0.001). In distinguishing leukemia from healthy controls, the cut-off value MO-WY 804 was obtained, with sensitivity; 52.6%, specificity; 96.3% (p <0.001). While distinguishing from reactive controls, the cut-off value of MO-WY 901 was obtained, with sensitivity; 46.1%, specificity; 85.7% (p = 0.299). NE-WY values indicated superior sensitivity and specificity compared to MO-WY in the early detection of acute leukemia.